About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Approves Drug to Limit Toilet Trips During Night

by Bidita Debnath on March 5, 2017 at 11:12 PM
Font : A-A+

FDA Approves Drug to Limit Toilet Trips During Night

The US Food and Drug Administration (FDA) has approved a treatment for adults who wake up to urinate at least twice during the night.

FDA said it has approved Noctiva nasal spray only for adults with nocturia caused by nocturnal polyuria -- overproduction of urine during the night.

Advertisement


"Today's approval provides adults who overproduce urine at night with the first FDA-approved therapeutic option to help reduce the number of times a night they wake up to urinate," Hylton V. Joffe from FDA's Center for Drug Evaluation and Research said in a statement on Friday.

"It is important to know that Noctiva is not approved for all causes of night-time urination, so patients should discuss their symptoms with their health care provider who can determine the underlying cause of the night-time urination and whether Noctiva is right for them," Joffe added.
Advertisement

Nocturia (waking at night to urinate) is a symptom that can be caused by a wide variety of conditions, such as congestive heart failure, poorly controlled diabetes mellitus, medications, or diseases of the bladder or prostate.

Noctiva is taken daily, approximately 30 minutes before going to bed.

It works by increasing the absorption of water through the kidneys, which leads to less urine production.

Noctiva's efficacy was established in two 12-week, randomised, placebo-controlled trials on 1,045 patients 50 years of age and older with nocturia due to nocturnal polyuria.

Although these trials showed a small reduction in the average number of night-time urinations with Noctiva compared to placebo, more patients treated with Noctiva were able to at least halve their number of night-time urinations, and patients treated with Noctiva had more nights with one or fewer night-time urinations.

The most common side effects of Noctiva in clinical trials included nasal discomfort, cold symptoms (nasopharyngitis), nasal congestion, sneezing, high or increased blood pressure, back pain, nose bleeds, bronchitis and dizziness.

Noctiva is marketed by Milford, Pennsylvania-based Renaissance Lakewood, LLC for Serenity Pharmaceuticals, LLC.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
Test Your Knowledge on Sugar Intake and Oral Health
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Drugs Banned in India 

Most Popular on Medindia

Post-Nasal Drip Calculate Ideal Weight for Infants Blood Pressure Calculator Noscaphene (Noscapine) Find a Doctor Sinopril (2mg) (Lacidipine) Drug - Food Interactions Accident and Trauma Care Sanatogen Selfie Addiction Calculator
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

FDA Approves Drug to Limit Toilet Trips During Night Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests